Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2009-11-10

Clinical Trial Update: Betamethasone Dosing Interval - 12 or 24 Hours? [NA]

View source ↗

Summary

This completed trial investigates whether betamethasone should be administered at 12‑hour or 24‑hour intervals for antenatal use in preterm delivery.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • betamethasone (betamethasone)

Snippet

Sponsor: The Cooper Health System | Conditions: Preterm Delivery | NA | Status: COMPLETED